← IPO Calendar

Curis Lifesciences IPO IPO

Mainline7 Nov 202511 Nov 2025
Open
7 Nov 2025
Close
11 Nov 2025
3
Allotment
Listing
Fri, Nov 14, 2025
Price Band
₹120 to ₹128
Issue Size
21,50,000 shares (agg. up to ₹28 Cr)
Lot Size
1,000 Shares
Listing Date
Fri, Nov 14, 2025
Latest GMP
₹9
Est. Gain
7.03%
✦ AI Insight

GMP Trend

14-11-20259Est. ₹137+7.03%
13-11-20259Est. ₹137+7.03%
12-11-20259Est. ₹137+7.03%

Live Subscription

CategorySubscription (times)
Total52.57x

Restated Financials (₹ Cr.)

Period Ended31 Jul 202531 Mar 202531 Mar 202431 Mar 2023
Assets56.2942.5333.8829.75
Total Income19.5149.6535.8736.42
Profit After Tax2.876.114.871.88
EBITDA4.249.548.393.28
NET Worth19.1016.235.871.01
Reserves and Surplus13.1610.295.370.51
Total Borrowing15.3215.6217.0916.19
Amount in ₹ Crore

Peer Comparison

CompanyIssue TypeIssue SizeIssue PricePE RatioListing Day CloseListing Gain/Loss %LTP
Aptus Pharma Ltd.SME₹13.02 Cr₹7011.29₹84.84+21.20%₹240.60 (-3.51%)
Asston Pharmaceuticals Ltd.SME₹27.56 Cr₹12317.83₹124.95+1.59%₹67.20 (-8.57%)
Influx Healthtech Ltd.SME₹58.57 Cr₹9613.04₹126.20+31.46%₹282.15 (-2.71%)
Astonea Labs Ltd.SME₹37.67 Cr₹13527.36₹135.65+0.48%₹278.00 (-1.77%)
Accretion Pharmaceuticals Ltd.SME₹29.75 Cr₹10121.29₹82.95-17.87%₹165.65 (-0.21%)
Amwill Health Care Ltd.SME₹59.98 Cr₹11113.81₹93.25-15.99%₹43.39 (+3.04%)
Sat Kartar Shopping Ltd.SME₹33.80 Cr₹8114.87₹161.55+99.44%₹126.60 (-2.62%)
Onyx Biotec Ltd.SME₹29.34 Cr₹6126.81₹56.75-6.97%₹37.60 (-4.93%)
Rubicon Research Ltd.Mainboard₹1,377.50 Cr₹48555.75₹628.20+29.53%₹1,439.60 (+2.37%)
Amanta Healthcare Ltd.Mainboard₹126.00 Cr₹12634.59₹141.75+12.50%₹168.00 (+1.44%)
Anlon Healthcare Ltd.Mainboard₹121.03 Cr₹9117.67₹91.73+0.80%₹14.73 (-3.22%)
Senores Pharmaceuticals Ltd.Mainboard₹582.11 Cr₹39139.77₹557.80+42.66%₹1,405.10 (-3.68%)
Sai Life Sciences Ltd.Mainboard₹3,042.62 Cr₹549126.42₹764.65+39.28%₹1,272.00 (-1.60%)

Objects of the Issue

#Issue ObjectsEst Amt (₹ Cr.)
1Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities2.44
2Capital Expenditure towards Construction of a Storage Facility3.62
3Pre-payment/Repayment of outstanding Secured Loans1.86
4Product Registrations in other countries2.69
5Funding working capital requirements11.25
6General Corporate Purposes2.85
7Issue Expenses2.80
Total27.52

About Curis Lifesciences IPO

Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company that specializes in developing, manufacturing, and distributing a diverse range of products. The company manufactures pharmaceutical products globally and domestically on a loan license or contract basis, as well as for its own brand marketing. The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Products: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The company operates a state-of-the-art manufacturing facility in Sanand, Gujarat, adhering to stringent quality control measures to ensure product safety and efficacy. As of July 31, 2025, the company has 95 permanent employees. Competitive Strengths: Experienced Promoters and Management Team Wide range of Products Strategic Location of Manufacturing Facility Scalable Business Model Quality assurance + Read More

Contact Details

Curis Lifesciences Ltd. AddressPF-23, GIDC Sanand-IIIndustrial EstateSanandAhmedabad, Gujarat, 382110+91 99045 22543cs@curisls.comVisit Website